ML20086J716

Public Version of Rev 0 to Emergency Plan Implementing Procedure 1903.34, Administration of Potassium Iodide. W/831122 Transmittal & Receipt Form

ML20086J716
Person / Time
Site:	Arkansas Nuclear
Issue date:	11/22/1983
From:	James M. Levine ARKANSAS POWER & LIGHT CO.
To:
Shared Package
ML20086J715	List: ML20086J716
References
1903.34, NUDOCS 8401250060
Download: ML20086J716 (14)

Text

AD

.m ARKANSAS POWER & LIGHT COMPANY gy Arkansas Nuclear One TITLE: TRANSMITTAL FORM-NO.

1013.0211 REV. # 12 PC fl Arkansas Nuclear One Russellville, Arkansas Date 11-22-83 MEMORANDUM TO:

\\b% \\mE w\\mMw3 X FROM:

ANO DOCUMENT CONTROL

SUBJECT:

ANO MASTER PLANT tlANUAL UPDATE PROCEDURE NUMBER 1903.34 REV. # 0 PC #

TC #

PROCEDURE TITLE ADMINISTRATION OF POTASSIUM IODIDE i

PROCEDURE NUMBER REV. #

PC #

TC #

PROCEDURE TITLE PROCEDURE NUMBER REV. #

PC #

TC #

PROCEDURE TITLE The following pages of the indicated procedure (s) contains items which involve personal privacy or proprietary material.

PLEASE REMOVE THE INDICATED MATERIAL PRIOR TO DISTRIBUTION TO PUBLIC DCCUMENT ROOMS, PROCEDURE (S)

PAGE (S) l _

l PROCEDURE (S) HAS BEEN PLACED IN YOUR SET OF Tl!E PLANT MANUAL.

l / l PROCEDURE (S) SIIOULD BE PLACED IN YOUR SET OF TIIE PLANT ?!ANUAL.

NOTE:

PLEASE RETURN SIGNED TRANSMITTAL TO DOCUMENT CONTROL - 4TII FLOOR:

l SIGNATURE DATE UPDATED 8401250060 840118 PDR ADOCK 05000313 Y

pyg

ARKANSAS POWER & LIGHT COMPANY Arkansas Nuclear One FORM NO.

RECORD OF CHANGES AND REVISIONS 1000.06A E!!ERGENCY PLAN REV. # 12 FC #,

e j

i'/>3<

ADMINISTRATION OF POTASSIUM IODIlucSafety Related YES M NO i

Vs

$ %.N '. \\

1903.34 RE7. 0

.c\\ (;% ) 'I %,.)

wh*' 8 0 -

B'

! @D7

\\

iPCd PAGE 'NfV PC#

PAGE REV PC#

PAGE REV PC#

PAGE ' REV - PC(d IPAGE REV

~

1 0

2 0

3 0

)

4 0

5 0

6 0

7 0

8 0

9 0

10 0

l 1

11 0

12 0

l APPROVED BY:

APPROVAL DATE unda O

/N gh.u.

REQUIRED EFFECTIVE DATE:

,,., c f (General Manager) y.

3

. ~ - - - - - - - - - - -

PLANT M ANUA'.SECTION:

PROCEDURE / WORK PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF DD nFTBf fDT D AT h C_ C T f f?f Yn_nTnr

10. A_ 7-.74 O

ARKANSAS NUCLEAR ONE aevision

- --oATE m

,,,n s,e,

\\_,/

CHANGE

~ DATE 1.0 PURPOSE The purpose of this procedure is to provide guidance for the administra-tion of potassium iodide (KI) to ANO and contractor employees who have been, or may be, exposed to airborne radioiodine concentrations which could result in a thyroid dose equal to or greater than 10 rads.

2.0 SCOPE This procedure applies to all ANO an'd contractor employees prior to a planned exposure to radiciodine and after an accidental exposure.

3.0 REFERENCES

3.1 References used in preparation of this procedure:

3.1.1 NCRP 55, Protection of the Thyroid Gland in the Event of y

Releases of Radioiodine 3.1.2 IAEA Technical Report No. 152, Evaluation of Radiation Emergencies and Accidents 3.1.3 AP&L Management Directive ESD-83-11.

V 3.1.4 AP&L Memorandum, David Snellings to Tom Baker, NO-83-394,

. dated October 14, 1983 3.2 Faferences used in implementation of this procedure:

1 3.2.1 ANO Emergency Plan 1

3.2.2 Procedure 1903.60, " Emergency Supplies and Equipment" Patient Package Insert for Thyro-Block " (Potassium 3.2.3 Iodide), Wallace Laboratories, dated October, 1979 3.2.4 Procedure 1622.015, " Bioassay Sampling Program" 3.2.5 Procedure 1609.003, "Use of Respiratory Equipment" 3.3 Related ANO procedures:

3.3.1 1000.31, " Radiation Protection Manual" 3.3.2 1000.33, "ANO ALARA Manual" A()

(

l l

PLANT M ANU AL SECTION:

PROCEDURElWORX PLAN TITLE:

NO:

ENERGENCY PLAN ADMINISTRATION OF FROCEDURE POTASSIUM IODIDE 1903.34 PAGE 2 of 12 (o

ARKANSAS NUCLEAR ONE aEvisioN 0 DATE 11/01/83

_j CHANGE DATE 4.0 DEFINITIONS None 5.0 RESPONSIBILITIES 5.1 The Duty Emergency Coordinator / Recovery Manager is responsible for the overall control and implementation of this procedure.

5.2 The Health Physics Superintenden't is responsible for assessing pre-and post-exposure dose, for assessing the need for the administration of KI and for advising th>> Duty Emergency Coordinator / Recovery Mana-ger of the need for the use of KI.

5.3 The Medical Team Leader is responsible for the administration of KI to the appropriate individuals.

6.0 INITIATING CONDITIONS The provisions of this procedure shall be invoked when either of the following conditions are met.

3 6.1 An individual, or individuals, is preparing to enter an area con-(~)

taminated with airborne radioiodine and he is judged by the Health Physics Superintendent to be at a significant risk of incurring a i

thyroid dose of equal to or greater than 10 rads.

l 6.2 An individual, or individuals, has been accidentally exposed to air-borne radiciodine and his (their) thyroid dose is expected to be equal to or greater than 10 rads.

NOTE:

To be most effective, KI must be administered prior to exposure to radioiodine.

If, for any reason, initial KI administration is delayed for longer than 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> after exposure, only limited thyroid blocking will occur.

7.0 PROCEDURE 7.1 Using Attachments 1 and 2, the Health Physics Superintendent shall determine if the projected thyroid dose will be equal to or greater than 10 rads. Document the estimate on Form A.

If the thyroid dose is projected to be less than 10 rads, proceed to Step 7.6.

NOTE:

If the thyroid dose is projected to be less than 10 rads, KI is not to be used.

p,

-v)

PLANT MANUAL SECTION:

PROCEDURUWORK PLAN TITLE NO:

l EMERGENC'l PLAN ADMINISTRATION OF PROCEDURF POTA99 TITM TonTnF ion? 71 PAGE q nf 17 ARKANSAS NUCLEAR ONE aEvisioN n oaTE

, vnw o(_)

CHANGE DATE 7.2 If the projected thyroid dose is apparently greater than 10 rads but is not within the bounds of the Thyroid Dose Graph, Attachment 1, the projected dose may be calculated as follows:

X(pf)XTime Dose in Rads = 2.51 x 104 Where Q = airborne iodine concentration in pCi/cc PF = respiratory equipment protection factor (Attachment 2)

Time = exposure time in minutes If this calculation is made, the results shall be documented in Part A of Form A.

7.3 The Health Physics Superintendent shall notify the Duty Emergency coordinator / Recovery Manager of the projected thyroid dose.

7.4 The Health Physics Superintendent should contact Millard-Henry Clinic (MHC) and inform the MHC physicians (preferably Dr. Teeter, Carter, or New) of the need to administer KI.

NOTE:

The Medical Staff of MHC has previously concurred with the administration of KI under specified conditions. This notifi-cation is for information purposes only, and administration of f-~)

KI should not be delayed pending contact with MHC.

(_

7.4.1 The Duty Emergency Coordinator / Recovery Manager shall docu-ment the Duty Emergency Coordinator / Recovery Manager's authorization for the administration of KI and the notifi-cation of the MHC physician in the Duty Emergency Coordi-nator/ Recovery Manager's Log.

If contact was not made earlier with a MHC physician, continue efforts to establish contact.

7.5 The Duty Emergency Coordinator / Recovery Manager shall instruct the Medical Team to report to the First Aid Room and prepare for KI administration.

7.5.1 The Health Physics Superintendent shall transfer the Form A's, with Part A completed, to the First Aid Room when the Medical Team is activated for KI administration.

7.5.2 The Duty Emergency Coordinator / Recovery Manager shall in-struct individuals who are to be offered KI to report to the First Aid Room.

(3

\\_J l

bbbb Mkb.

fh PROCEDURE

?OTASSIUM IODIDE 1903.34 PAGE 4 OI 14 O

ARKANSAS NUCLEAR ONE aavision u o*TE 11/ul/os CHANGE DATE 7.5.3 The Medical Team Leader shall direct the individuals about to receive KI to read the Thyroid Blocking Agent Precau-tions Leaflet (Attachment 3).

7.5.4 The Medical Team Leader shall complete Part B of the Potassium Iodide Administration Form, Form A, for each individual.

7.5.5 After the individuals have read the precaution leaflet (Att. 3) and their Potassium Iodide Administration Form has been completed, they shall sign their Form A.

The Medical Team Leader shall stress to the individuals that the taking of KI is voluntary. Prior to taking the KI, the Health Physics Superintendent shall advise the indi-viduals of the projected thyroid dose, explain the protec-tion offered by the KI, and discuss the potential bio-logical effects of the projected thyroid dose followir.g KI administration.

If any individuals choose not to take the KI, the Medical Team Leader shall notify the Duty Emergency Coordinator / Recovery Manager and the Health Physics Super-intendent. The Health Physics Superintendent shall advise them of the potential biological effects of the projected thyroid dc.e without KI protection. This action shall be

~N noted on :he individual's Form A.

(U i

7.5.6 When each individual's Potassium Iodide Administration Form, Form A, has been signed, each individual will be issued a KI tablet to be taken at that time.

7.5.7 Each exposed individual shall be instructed to return each morning for the next 4 consecutive days for an additional KI tablet.

Daily administration of KI shall be documented on Form B.

The initials of the Medical Team member ad-ministering the KI and the date of administration shall be noted on the form in the space provided. This step should complete Part B of Form A.

NOTE: KI intake should continue for four days past the last ra-diciodine exposure. However, radioiodine exposure must be limited such that KI is taken for no more than 10 consecu-tive days.

7.6 Whole body counts shall be conducted in accordance with Health Phy-sics Procedure 1622.015, " Bioassay Sampling Program", within the fol-lowing guidelines:

(

\\

9

PLANT MANUAL SECTION:

PROCEDURE / WORK PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF PROCEDURE POTA99 Tim inninF lon7 of PAGE q np 3 9 (7

ARKANSAS NUCLEAR ONE aEvis:oM n

oaTE n intie3 N-CHANGE DATE 7.6.1 Individuals Occupationally Exposed For individuals preparing to enter a radioiodine-contaminated area and whose projected thyroid dose is expected to be equal to or greater than 10 rads, a whole body count should be performed prior to exposure (if practical). A whole body count should be performed post-exposure as soon as' practical (it is suggested that a whole body count be performed within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br />). Additiona.1 whole body counts should be performed at the Health Physics Superintendent's discretion consistent with the requirements of Procedure 1622.015.

7.6.2 Individuals Accidentally Exposed For individuals accidentally exposed to radioiodine, a whole body count should be performed as soon post-exposure as practical (it is suggested that a whole body count be performed within 48 hours5.555556e-4 days <br />0.0133 hours <br />7.936508e-5 weeks <br />1.8264e-5 months <br />). Additional whole body counts should be performed at the Health Physics Superintendent's discretion consistent with the requirements of Procedure 1622.015.

7.7 Additional bioassay (e.g. urinalysis and thyroid function studies)

(_)3 shall be performed if deemed necessary by either the NHC physician or the Health Physics Superintendent.

7.8 Forms A and B shall be forwarded according to the following instruc-tions:

7.8.1 The Medical Team Leader shall turn over Forms A and B to the Health Physics Superintendent as they are completed.

7.8.2 The Health Physics Superintendent shall complete Part C of Forn A.

7.8.3 The Health Physics Superintendent shall assure that copies of Forms A and B are placed in the appropriate individual's Exposure File and that internal doses, as determined by I

Procedure 1622.015, " Bioassay Sampling Program", are cal-culated and documented in each individual's Exposure File.

7.8.4 After copies of the forms are sent to the individual's Exposure File, the Health Physics Superintendent shall forward completed forms to the Duty Emergency Coordinator /

l Recovery Manager for retention.

,o 1

l

PLANT M ANUAL SECTION:

PROCEDURE / WORK PLAN TITLE:

NO:

EIIERGENCY PLAN ADI!INISTRATION OF PROCEDURE POTASSIUM IODTDF 1903.34 PAGE 6 of 12 O

ARKANSAS NUCLEAR ONE aavisiON n oATE

iiroien, CHANGE DATE 8.0 ATTACHMENTS 8.1 Attachments 8.1.1, " Thyroid Dose Graph" 8.1.2, " Respiratory Equipment Protection Factors" 8.1.3, " Potassium Iodide Precaution Leaflet" 8.2 Forms 8.2.1 Form 1903.34A - Potassium Iodide Administration Form 8.2.2 Form 1903.34B - KI Issue Record O

O

E PLANT MANUAL SECTION:

PROCEDURElWORK PLAN TITLE:

NO:

E!!ERGENCY PLAN ADMINISTRATION OF PROCEDURE POTASSIUI! IODIDE 1903.34 PAGE 7 of 12 0:.. -

ARKANSAS NUCLEAR ONE aevision o o*TE 11/01/83 CHANGE DATE

-,s ATTACHl!ENT 1 4

. 00 THYROID DOSE GRAPH 7.-

+

Y.

. _ _. _ _ _ _ _^ _ ~ _ _. _. _

~~~

. _ _. _ _ _ ' ~ ~.

~

^] T,

.. _d c y

.pf.

_ - -. ~ _ _..

.w_.

, g,

. p..,- +

(.

L.7 '

' - - ' ~ _ _

~~

- u

.. _. _ J _ -

- - {_..

q__ --_ _ _

j

___.r

-00

- - - - - -~~~-- ~

--.__ ~

l

- ;_ THYROID DOSE. ~~

~

THYROID DOSE - - - - - -

_<10 Rads ' __i _ _A

>10 Rads

..- _ -._ -y n

_ _ _ =

l

(

~'

7'-'

-~

=.=-r

-=:.=-:

I=2;;- -. = _ _ :.=1.'

r_

m

~

W g

pian 9 - ~ ~ r f : - O_i.~.~2:_.

~

l-12

. =

._:_ = : - - : :_ =._

=:

ji

- --. J 2~.

- ~. _. _ _ _ _. _

~

--~l~ J ~

~~~~~~-^!

~

.._.__.7_..._.__. _. _ _

~}

~~

~~~---

_' y 0 _

j g ~

~ " ~ _ -

- ~ ~ ~ ~ ~ ~ ~ ~ ~

^^

k

_ =

_a

~ ^ - -

.j iD --

I-'i' 1 di-5_1.

.-~r u_

~

'~ '

~~

_. _._ _.a._ _ n _ _ ;

._q s

g,

(

i 10-7 10-C 10-5 "10-4 '~~

I-131 Concertration (in uC1/cc)/P-otection Factor t

k T

-'*7 Y-

PLANT M ANUAL SECTION:

PROCEDURElWOR;t PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF PROCEDURE POTARSTUM TODTDF 1901 14 PAGE R of 12 o/

ARKANSAS NUCLEAR ONE aEvisiON n DATE

,, ini in i

\\-

CHANGE DATE ATTACHUENT 2 RESPIRATORY EQUIPMENT PROTECTION FACTORS Equipment Gases, Vapors Air Purifying Bearing NIOSH Approvals Series TC-21C 1.

Negative Pressure Full Facepiece (includes Duo-Flo in filter mode) 1 2.

Positive Pressure Air Purifying Full Facepiece, Hood, Half Facepiece 1

Atmosphere Supplying Airline (in-cluding Duo-Flo in airline mode)

Bearing NIOSH Approval Series TC-19C

(_)s 1.

Full Facepiece 2,000 i

2.

Half Facepiece 1,000 3.

Suit 1

4.

Hood 1,000 Atmosphere Supplying Self-Contained Breathing Apparatus Bearing NIOSH Approval Series TC-13F 1.

Pressure Demand Air Mask 10,000 2.

Recirculating Pressure-Demand 5,000 (Bio-Pak) l l

i r-PLANT MANUAL SECTION:

PROCEDUREIWORK PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF PROFFnHRF pnTA44 Tim TonTne long - > +

PAGE o ng in O

ARKANSAS NUCLEAR ONE aevisioN n D*1E

,,,n,, e 3 CHANGE DATE ATTACHHENT 3

)

Page 1 of 2

,s..

a..a.e

.o, THYRO BLOCK" i,0f a59ute eOOsoEn l

.pronom e4 :.uo ta>> e um E

• E % s. #

isotweersteo Ett f astE15 and sotuTioN u s,

TAKE POTASStUM IODIDE ONLY WHEN PUBLIC HEALTH OFFICI A14 TELL YOU. IN A RADI ATION j

EMERGENCY. R A DIO ACTIV E IODINE COULD DE j

RELEASED INTO THE AIR POTASSIUM IODIDE (A FORM OF IODINEl CAN HELP PROTECT YOU.

IF YOU ARE TOLD TO TAKE THIS MEDICINE. TAKE IT ONE TIME EVERY 24 HOURS, DO NOT TAKE IT MORE OFTEN MORE WILI NOT HELP YOU AND MAY IN-CREASE THE RISL JF SIDE EFFECTS DO NOT TAKE THIS DRtlG IF YOU KNOW YOU ARE ALLERGIC TO IODIDE (SEE SIDE EFFECTS BELOW.I INDICATIONS THYROID BLOCKING IN A RADIATION EMERGENCY ONLY DIRECTIONS FOR USE 4, A Use only se darected by tiLate or local pubbC health authorstaes an O

't the event of a rad 4auon emergency.

DOSE Tablets.

ADULTS AND CHILDREN 1 YE AR OF AGE OR OLDER. One ela tablet once a day Crush for smailchMren.

BABIES UNDER 1 YEAR OF AGE.

Onehalf (1>2) tablet once a day Cruen first.

Solutmst ADULTS ANDCHILDREN 1 YEAROF AGE OR OLDER. Add 6 drops to one half glass of hquid and drink each day.

BABIES UNDER 1 YEAR OF AGE:

Add 3 drops to a small amount of hquid once a day.

For ad dosage forma: Tal6e for 10 days unless directed otherwise by State or local pubbc health authoriues.

Store at controlled room temperature between 15* and 30*Ci59' to 86'F) Keep container tightly closed and protect from bght Do not use the solution if it appears bro = nash m the noaale of the bottle.

W AR NING

~

Potassaanm nodsde shouki not be asned by people auergse to nodsde Keep out of the reach of chddren. In case of overdo,e or allergic reaction, contact a physician or the pubbc health authority DESCRIPTION Each THYRO BLOCKW TABLET contains 130 mg of g

potassium sodide-Each drop of THYRO liLOCK" SOLUTION contains 21 tra of potssisum iod d4 C

a e

(.,g p

K

r e

PLANT M ANUAL SECTION:

PROCEDURE / WORK PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF PROCEDURE POTASSIUM TODTDF 1901_34 PAGE 10 of 12

-)

ARKANSAS NUCLEAR ONE aevision n o*Ta ii/niza, CHANGE DATE ATTACHMENT 3 Page 2 of 2 HOW pOTASStuu IODIDE Wops Certaan le=ms of iodme help vour thyroid gland =nra right M ost people get the einhne they need from fonds. Iske endised salt or huh The thyrned ran % tate ~or hold only a certain amount of sodine la a rodase men entregenes. redepe< teve wene mes he released m the ear l'his material mov he breathed nr smanneed it mas enter the ths re sd gierut and damage it. The demure would prw habh not she* itMf for seers Children are me t huelv to han thyroid damage If you take potassium sodide. at will Idl-up your thyroid gland Thas reduces the chance that harmful radaoactave modme edi enter the thyroid gland WHO SHOULD NOT TAKE POTASStuM IODIDE The only peop6e who should not tame potassium nodade are people who know they are ellerpe to sodade, You may take potassaum iodsde even af you are taking medicines for a thyrosd problemifor example. a thyroid horrnone or anuthyeoid drugt Pregnant and nursing women and bat..es and chddren may also take than drug HOW AND WHEN TO TAKE POTASSIUM IODIDE Potassium todade should be taken as soon as possible ayer public health of hcials tell you. You should take one done every 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> More wdl not help you because the thyroid con " hold"on-ly brruted amounts of sodine. Larger doses edi meresse the rise of side oflects You =di probably be told not to take the drug for more than 10 days SIDE EFFECTS Usually, side effects of potassium sodide happen when people take lugher doses for a long ume You should be careful not to take more than the recommended dose or talie it for longer than g

• e d-you are told. Side effects are unkkely because of the low dose and

]

the short tame you wdl be taking the drug.

Q Possible side effects include slun rashes. sweihng of the sahvary glands. and "modism" tmetallac taste, burnans mouth and throat.

sore teeth and gums. symptoms of a head cold. and sometunes stomach upset and diarrheat A few people have an adergsc reaction with more serious symp toms These could be fever and joint pains. or swelLng of parts of the face and body and at t mes severe shortness of. breath requar-mg ammediate med4 cal attention.

Talung todade may rarely cause overacuvity of the thyro d gland, underecuvity of the thyroid gland. or enlargement of the thyroid gland Igoster).

1 WHAT TO DO IF $10E EFFECTS OCCUR If the made effects are severe or if you have an alleroc reacuen.

(

stop talung potassium iodade. Then, if possible, call a donor or pubbc health authority for instruchons.

HOW SUPPLIED THYROBLOCKW TABLETS iPotassium todide. U S P.i bot-ties of I 4 tablets IN DC 0037 441: 20 ) Esch = lute. round. scored tablet contams 130 mg potassium iodade.

THYRO BLOCKW SOLUTION iPotassium lodide Solution.

U.S P.i 30 rn1 si fL ca.1 baht resistant, measured-drop dispensing uruta (NDC 0037-4287-:st Each drop contains 21 mg potassium nodide.

waLLACE LABORATOniES g

I Oms.on of t

CANTER W ALLACE, iNC Cranoury. how msev G8512 CW-107919 a0d9 assue 10A i

l C

l

~

1 l

l 1

l bCA k

E

O' PLANT M ANUAL SECTION:

PROCEDURE / WORK PLAN TITLE:

NO:

EMERGENCY PLAN ADMINISTRATION OF PROFFnfiRE POTA99TTHf TonTnP lon? 7.1 PAGE 11 nf 17 o

ARKANSAS NUCLEAR ONE aEvisioN n oATE

>>/ni/a, CHANGE DATE m

ARKANSAS POWER & LIGHT COMPANY g

Arkansas Nuclear One f

NPOTAsstUM 100f rE m'INYsTMTTOM Fn#M

? " ? ' i t.

REV. 60 PC #

PART A Name of Exposed Individual Last Middle First Social Security Number TLD Badge Number Projected / Actual Estimated Duration of Exposure Minutes In: Concentration pCi/cc in Air Respiratory Protection Worn During Exposure? Yes _ No _

If "Yes", Pespiratory Equipment Protection Factor (Attachment 2) =

If "No", explain why Projected Thyroid Dose from Thyroid Dose Graph

> 10 RAD or

< 10 RAD (Check One) y s' h

/

jj

(]

Health Thysics Superintendent Date Date of Exposure Time of Exposure Rads If calculated, projected thyroid dose (per paragraph 7,.2) =

/

Health Thysics Superintendent Date PART B Known Iodide Allergy / Previous Allergic Reactien? Yes No Unknown If "Yes", do not administer KI.

If " Unknown", contact the Health Physics Superintendent and/or the Duty Emergency Coordinator / Recovery Manager for further guidance.

I verify that I have read and understand the precaution leaflet and I understand that taking thyroid blocking agent (i.e., KI) is strictly voluntary.

I do - do not - (check one) choose to take KI.

/

/

Exposed Individual Date Time Potassium Iodide Tablet Issued By (and arrangements made to administer KI for the next 4 consecutive days per Section 7.5.7):

/

/

Medical Team Leader Date Time NOTES

• • • • .a...............****.................***********...*....**=**=.*

.=

aaaaa==****

g; FART C I have reviewed the above information.

/

H.ealth Physics Superintendent Date iV bCw N

m e~

e NN5hMuAggrioN:

gfjgggggy PyNTITLE:

NO:

PROCEDURE POTASSIUI! IODIDE l'03.34 PAGE 1 #- 05 14 et O

ARKANSAS NUCLEAR ONE aavision u oaTe 22'u2'o#

CHANGE DATE ARKANSAS POWER & LIGHT COMPANY Arkansas Nuclear One KT ISSt'E RECORD l FORM NO. py,

N

/

REV. #0 PC #

Exposed Individual's Name Social Security Number

/

TLD Projected / Actual Exposure Date of Exposure l

Dose i

Dosage i

Date i Initials of Medical Team l l Number l (milligrams) l Administered l Member Administering Dose i I

I I

l I

i1 1

I I

i O

l2 l

l l

l l3 I

I I

I l

i I

I I

l l4 I

I I

I I

I I

I I

15 I

I I

I I

I I

I I

I6 I

I I

I I

I I

I I

I7 l

l l

l l

l 1

I I

l8 l

l l

t I

I I

I I

I9 I

I I

I I

I I

I I

I 10 l

I I

I l

l

-~

O s

8MJ ehm-

-